Skip to main content

Hormone Tx Tied to Reductions in Insulin Resistance

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 11, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Sept. 11, 2024 -- Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.

Tanya Li, from Reading Hospital Tower Health in West Reading, Pennsylvania, and colleagues conducted a systematic literature review to identify randomized controlled trials (1998 to 2024) that evaluated the effect of HT on insulin resistance, measured by the homeostasis model assessment of insulin resistance (HOMA-IR), in postmenopausal women without diabetes, hypertension, or cardiovascular diseases.

Based on pooled data from 17 included trials (29,287 postmenopausal women), the researchers found the HOMA-IR was significantly reduced in women who received HT (overall effect: raw mean difference [RMD], −0.24; P < 0.001; I2 = 60.3 percent) compared with those who received placebo. The HOMA-IR was significantly reduced in both women who received estrogen alone (RMD = −0.42; P < 0.001) and those who received estrogen plus progestogen (RMD = −0.14; P = 0.005) versus those who received placebo.

“Our analysis showed that both types of hormone therapy, including oral and transdermal routes, significantly reduced insulin resistance in healthy postmenopausal women, although estrogen alone was associated with a more prominent reduction when compared to a combination hormone therapy," lead researcher Xuezhi Jiang, M.D., also from Reading Hospital Tower Health, said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Survey Reveals Women May Be Experiencing Perimenopause in Their 40s

FRIDAY, April 25, 2025 -- Six in 10 women believe they will hit menopause in their 40s, according to survey results released April 8 by The Ohio State University Wexner Medical...

Common Photosensitizing Drugs Increase Skin Cancer Risk

TUESDAY, April 1, 2025 -- Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology...

Low Creatinine-to-Cystatin C Ratio Tied to Lower Muscle Volume in Midlife Women

MONDAY, March 31, 2025 -- Among middle-aged women, low creatinine-to-cystatin C ratio (CCR) at baseline is associated with lower fat-free muscle volumes and poorer gait speeds 6.6...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.